Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 30, 2024, to February 6, 2025 [3]. - Allegations include that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which negatively affected gross margins and overall financial results [3]. Impact on Financial Statements - The complaint claims that the defendants overstated the effectiveness of cost reduction measures and the health of gross margins while downplaying related issues, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 3, 2025, to participate in potential recovery and receive updates on the case [4]. - Registration does not require appointment as a lead plaintiff and incurs no cost or obligation [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements [5].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that affected investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures and misrepresented the health of its gross margins while downplaying related issues [2]. Group 2: Investor Participation - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 30, 2024, to February 6, 2025 [3]. - Allegations include that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which negatively affected gross margins and overall financial results [3]. Impact on Financial Statements - The complaint claims that the defendants overstated the effectiveness of cost reduction measures and the health of gross margins while downplaying related issues, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 3, 2025, to monitor the case's progress and potentially seek lead plaintiff status [4]. - Registration is free and does not obligate shareholders to participate in the case [4]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][2]. Allegations - The complaint alleges that Canopy Growth Corporation incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues [1]. - As a result, the public statements made by the defendants are considered materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from May 30, 2024, to February 6, 2025, and shareholders are encouraged to register by June 3, 2025, to participate [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Canopy Growth Corporation for alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by June 3, 2025 [2][4]. Group 1: Allegations Against Canopy Growth - The complaint alleges that Canopy Growth and its executives made false and misleading statements regarding the company's financial health and cost management, particularly related to the Claybourne product launch and Storz & Bickel vaporizer devices [4]. - Canopy incurred significant costs associated with the production of Claybourne pre-rolled joints, which negatively impacted gross margins and overall financial results [4]. - The company overstated the effectiveness of its cost reduction measures and downplayed issues affecting gross margins, leading to materially false public statements [4]. Group 2: Financial Results and Market Reaction - On February 7, 2025, Canopy reported a gross margin decrease of 400 basis points to 32% in Q3 2025, primarily due to costs related to the Claybourne product launch and increased indirect costs from Storz & Bickel devices [5]. - Canopy reported a wider-than-expected loss of C$1.11 per share in Q3 2025, compared to the C$0.48 per share loss estimated by analysts [5]. - Following the announcement of these financial results, Canopy's share price fell by $0.76, or 27.34%, closing at $2.02 per share on February 7, 2025 [7].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures and the health of its gross margins while downplaying related issues, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that affected investors between May 30, 2024, and February 6, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the production of Claybourne pre-rolled joints and the launch of the Claybourne product in Canada [2] - It is alleged that these costs, along with indirect costs related to Storz & Bickel vaporizer devices, would negatively impact the Company's gross margins and overall financial results [2] - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Canopy Growth Corporation (NASDAQ: CGC). Shareholders who purchased shares of CGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/canopy-growth-corporation-loss-submission-form-2/? id=144669&from=4 CLASS PER ...

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Canopy Growth Corporation (NASDAQ: CGC). Shareholders who purchased shares of CGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/canopy-growth-corporation-loss-submission-form-2/?id=144427&from=3 CLASS ...